Hemispherian AS, a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce the closure...
AnchorDx, a world-leading developer of cancer early detection solutions, announced the first patient enrollment for the UriFind® bladder cancer assay clinical trial in the U.S.,...
Vieworks, a leading digital x-ray imaging solution provider based in South Korea, will be exhibiting its complete lineup of DR flat panel detectors (FPD)...
